在临床皮层内AMPA/甲酸盐受体的激活是可卡因潜伏期需要的
Laura L Huerta Sanchez1, Mirette G Tadros1, Hoa H T Doan1
1Department of Psychological and Brain Sciences, University of California, Santa Barbara, Santa Barbara, CA, United States.
Frontiers in psychiatry
|September 2, 2025
概括
在中部前额皮层的α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) 受体对于可卡因渴望的潜伏至关重要. 阻断这些受体在前肢区域减少后期戒断的渴望.
科学领域:
- 神经科学
- 行为神经科学
- 关于成的研究
背景情况:
- 渴望的潜伏是一种行为现象, 在戒断期间, 渴望药物会加剧.
- 这种现象与中部前额皮层 (mPFC) 的谷氨酸释放有关,特别是前额皮层 (PL) 亚区域.
- 阿尔法-氨基-3-基-5-甲基-4-异醇酸 (AMPA) 受体是这种谷氨酸效应的潜在媒介.
研究的目的:
- 研究mPFC中的AMPA受体 (AMPARs) 在可卡因渴望的潜伏过程中的作用.
- 确定PL次区域的AMPAR是否对于潜伏中的可卡因渴望是必要的.
- 检查AMPAR亚单元表达与潜伏期渴望之间的关系.
主要方法:
- 鼠被训练自行使用可卡因.
- 在早期或晚期戒断期间,AMPA/ 甲酸盐受体对抗剂NBQX被输入PL.
- 测试了诱导可卡因的行为,并通过免疫检测评估了AMPAR子单元的表达.
主要成果:
- 在PL内使用NBQX阻断了晚期戒断的化渴望,而不是早期戒断.
- 在早期戒断期间的雌性大鼠中,PL内NBQX增加了提示诱导的可卡因寻找.
- 在mPFC中没有发现与化可卡因渴望相关的AMPAR子单元表达的显著变化,除了化可卡因渴望的男性IL中的GluA1升高.
结论:
- 在PL中AMPA/甲酸盐受体是驱动化可卡因渴望所必需的.
- 在下肢皮层 (IL) 中的AMPA/甲酸盐受体可能在糖渴望中发挥作用,特别是在男性中.
更多相关视频
相关概念视频
Adrenergic Agonists: Indirect-Acting Agents
1.8K
Indirect-acting adrenergic agonists potentiate the effects of endogenous catecholamines through different mechanisms without directly binding to adrenoceptors.
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral...
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral...
1.8K
Drug Abuse and Addiction: Pharmacological Phenomena
655
Drug dependence, abuse, and addiction are complex phenomena that can precipitate various abnormal states. Physical dependence refers to a state of pharmacological adaptation to a drug. This adaptation often results in tolerance—a reduced response to the drug after repeated administrations. When the drug use is abruptly stopped, withdrawal symptoms occur due to the body's need to readjust from the pharmacologically induced imbalance. However, tolerance and withdrawal symptoms do not...
655
CNS Stimulants: Cocaine, Amphetamines and Cannabinoids
324
CNS stimulants, such as cocaine, amphetamines, and cannabinoids, have varying structures and mechanisms of action that lead to different therapeutic effects and side effects. Cocaine, with its molecular formula C17H21NO4, is a tropane alkaloid and a tertiary amino compound. It has two chemical forms: the hydrochloride salt and the "freebase." The former is in powder form, while the latter involves removing the hydrochloride salt to create a form that can be smoked. Cocaine exerts its...
324


